Thieves of public health funds? New York University alumna slams Hontiveros, Garin over alleged PhilHealth fund anomalies

Krizette Laureta Chu, a well-known writer and staunch supporter of President Rodrigo Roa Duterte, lambasted two notable affiliates of the previous Aquino administration, Senator Risa Hontiveros and former DOH Secretary Janette Garin, in one of her published Facebook post.






Chu's remarks are anchored on the alleged sabotaging of public health (PhilHealth) funds by the above-mentioned officials.

Risa Hontiveros photo from Canadian Inquirer; Janette Garin photo from Twitter

According to Krizette Chu, both Hontiveros and Garin whom she alleged to have benefitted a lot from the funds of PhilHealth, had received considerable amount charged from the PhilHealth funds. This, as how Chu put it, led to the bankruptcy of the health insurance company which deprived many Filipinos of their right to quality and free public health services and benefits.

READ THE FULL POST BELOW:

“SABI NA NGA BA! WALA NG PERA ANG PHILHEALTH DAHIL PINAKI ALAMAN NI JANETTE GARIN

Sino ang nasa Philhealth circa 2015, di ba Ikaw Senator Risa Hontiveros? Anong alam mo dito, babae ka?

Sino ang nasa DOH circa 2015, di ba ikaw, Janette Garin?




Kelan ang usapang DENGVAXIA purchase? Di ba around this time?

At bakit si JANETTE GARIN ang highest paid secretary nung time ni Noynoy? She received 2.2 million a year, plus another 400k for being a chairperson of PHILHEALTH?

Anong meron sa kanya?


Screengrab photo from CNN
Ang hilig nyo tumingin sa conflict of interest, Hontiveros, unahin ninyo ito. Chairman ng PHILHEALTH tapos trinansfer lang din nya sa DOH yung funds nya sa PHILHealth, ngayon magkaka leche leche ang PHILHEALTH.




There is no greater crime than stealing from PUBLIC HEALTH FUNDS! Ilang tao ang hindi mabibigyan ng tulong kasi binankrupt nyo ang PHILHEALTH.

No wonder pinapa resign lagi si Duterte. Daming ka lechehan nila ang malalaman.

Mga P***** IN* TALAGA. Ito yung mga kalidad ng mga babae ninyo." 




Post a Comment

0 Comments